What Are the Top Pharma Challenges Right Now?
The opioid epidemic is far from over, but it may slip behind other challenges. COVID-19 obviously tops the list of new problems and drug pricing and affordability will continue to soak up time and attention.
COVID-19 Costs Hit Insurers
They are waiving cost sharing for COVID-19 treatment. How large will premium increases be next year?
Point-of-Care Tools in Pharmacy Take Off
New point-of-care tools offer greater transparency.
Accessibility and Affordability of Gene Therapy
Payers are finding ways for members to afford expensive specialty drug treatments.
What Are Authorized Generics?
Authorized generics have been gaining popularity with pharmaceutical manufacturers, but just how do they impact pharmacies?
Drug Shortages Continue to Burden Healthcare
Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.
Drug Price Reform Takes Off in 2019
Opportunities to lower drug prices, as promised by President Trump’s American Patients First Blueprint, are picking up steam, some progressing more quickly than others.
Indication-based Formulary Design Chases Medicare Market
CMS introduced indication-based formularies as a voluntary tool for plans to implement in 2020.
How Payers Are Keeping Specialty Drug Costs Down
The real-world strategies used to manage the high cost of specialty meds.
The State of Drug Rebates
The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?
How Health Systems Use Pharmacists to Reduce Readmissions
The stakes have never been higher in reducing readmissions and hospitals are leveraging pharmacists’ expertise and putting them at the forefront of readmission reduction programs
Top 5 Therapeutic Areas for 2019
The biggest drug categories and medications set for approval this year.
Top 6 Pharmacy Challenges of 2019
What experts say will be the year’s biggest problems, and what can be done about them.
Medical Foods Strive for Insurance Coverage
These products aid in treating several conditions, but are insurers paying for them? Find out.
PBM Performance-Based Pharmacy Networks Aim to Cut Costs
Innovative PBM performance-based pharmacy networks focus on reducing costs and Improving clinical outcomes
New Drug Pricing Tools Could Save Money
In response to the lack of transparency, health organizations are creating drug pricing tools that deliver patient-specific pricing. Here’s how they work.
Formulary Drug Exclusions on the Rise: What Health Execs Should Know
How New Initiatives Could Affect Generic Drug Costs
Prices of more than 20% of generic drugs increased more than 100% between 2010 and 2015.
Right to Try Pros and Cons
Legislation removes FDA involvement when patients seek experimental medications. Here’s what critics and proponents say.
More Insurers Pass Point-of-Sale Drug Discounts to Consumers
2 Commerce Drive Cranbury, NJ 08512